PLx Pharma Winddown Corp. Quarterly Cost of Revenue in USD from Q3 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
PLx Pharma Winddown Corp. quarterly/annual Cost of Revenue history and growth rate from Q3 2020 to Q3 2022.
  • PLx Pharma Winddown Corp. Cost of Revenue for the quarter ending September 30, 2022 was $1.46M, a 62.7% decline year-over-year.
  • PLx Pharma Winddown Corp. Cost of Revenue for the twelve months ending September 30, 2022 was $4.34M.
  • PLx Pharma Winddown Corp. annual Cost of Revenue for 2021 was $4.81M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $4.34M $1.46M -$2.45M -62.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $6.79M $820K +$820K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $5.97M $1.17M +$1.17M Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $4.81M $892K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $3.91M +$3.91M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.